FDA Proposes Reducing Animal Testing in Cancer Drug Development
The FDA released draft guidance recommending fewer animal tests in cancer drug safety studies to streamline development and reduce reliance on non-human primates
Health & Public Health covers major developments in healthcare, medicine, medical research, public health, food safety, health policy, insurance, drug safety, and safety issues affecting readers in the United States and around the world. This section focuses on clear, factual reporting from credible sources, including government health agencies, medical research institutions, public health organizations, and trusted news outlets. Coverage may include FDA updates, NIH research, disease prevention, healthcare costs, medication safety, public health alerts, hospital systems, and policy decisions that affect patients and communities.